Metropolitan Life Insurance CO Albireo Pharma, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jun 14, 2023	BUY	$18.01 - $23.78 $19,576 - $25,848	1,087 New	1,087 $23.5 Million
Q3 2022 Jun 14, 2023	BUY	$16.32 - $26.37 $17,739 - $28,664	1,087 New	1,087 $21 Million
Q2 2022 Jun 20, 2023	BUY	$18.54 - $37.29 $20,152 - $40,534	1,087 New	1,087 $21,000
Q1 2022 Jun 20, 2023	BUY	$23.94 - $33.74 $26,022 - $36,675	1,087 New	1,087 $32,000
Q1 2022 Mar 30, 2023	SELL	$23.94 - $33.74 $82,976 - $116,942	-3,466 Reduced 76.13%	1,087 $32,000
Q1 2022 May 12, 2022	SELL	$23.94 - $33.74 $82,976 - $116,942	-3,466 Reduced 76.13%	1,087 $32,000
Q4 2021 Jun 21, 2023	BUY	$21.19 - $31.29 $96,478 - $142,463	4,553 New	4,553 $106,000
Q3 2021 Jun 21, 2023	BUY	$27.36 - $35.98 $124,570 - $163,816	4,553 New	4,553 $142,000
Q2 2021 Jun 21, 2023	BUY	$28.9 - $36.87 $131,581 - $167,869	4,553 New	4,553 $160,000
Q2 2021 Aug 16, 2021	BUY	$28.9 - $36.87 $131,437 - $167,684	4,548 Added 90960.0%	4,553 $160,000
Q1 2021 Jun 26, 2023	BUY	$32.03 - $42.85 $145,832 - $195,096	4,553 New	4,553 $160 Million
Q1 2021 May 14, 2021	SELL	$32.03 - $42.85 $145,672 - $194,881	-4,548 Reduced 99.89%	5 $160,000
Q4 2020 Jun 22, 2023	BUY	$31.56 - $42.16 $143,692 - $191,954	4,553 New	4,553 $170,000
Q4 2020 Mar 30, 2023	BUY	$31.56 - $42.16 $8,142 - $10,877	258 Added 6.01%	4,553 $170,000
Q4 2020 Feb 16, 2021	BUY	$31.56 - $42.16 $8,142 - $10,877	258 Added 6.01%	4,553 $171,000
Q3 2020 Jun 26, 2023	BUY	$23.19 - $41.61 $99,601 - $178,714	4,295 New	4,295 $143,000
Q2 2020 Jun 26, 2023	BUY	$14.82 - $29.92 $63,651 - $128,506	4,295 New	4,295 $113,000
Q2 2020 Mar 30, 2023	BUY	$14.82 - $29.92 $12,848 - $25,940	867 Added 25.29%	4,295 $113,000
Q2 2020 Aug 14, 2020	BUY	$14.82 - $29.92 $12,848 - $25,940	867 Added 25.29%	4,295 $114,000
Q1 2020 Jul 12, 2023	BUY	$11.67 - $27.23 $40,004 - $93,344	3,428 New	3,428 $56,000
Q4 2019 Jul 12, 2023	BUY	$16.92 - $28.96 $58,001 - $99,274	3,428 New	3,428 $87,000
Q4 2019 Mar 30, 2023	BUY	$16.92 - $28.96 $1,692 - $2,896	100 Added 3.0%	3,428 $87,000
Q4 2019 Feb 14, 2020	BUY	$16.92 - $28.96 $1,692 - $2,896	100 Added 3.0%	3,428 $87,000
Q3 2019 Jul 12, 2023	BUY	$20.0 - $31.88 $66,560 - $106,096	3,328 New	3,328 $66,000
Q2 2019 Jul 12, 2023	BUY	$30.67 - $37.86 $102,069 - $125,998	3,328 New	3,328 $107,000
Q1 2019 Jul 13, 2023	BUY	$22.22 - $32.21 $73,948 - $107,194	3,328 New	3,328 $107,000
Q1 2019 Mar 30, 2023	BUY	$22.22 - $32.21 $49,795 - $72,182	2,241 Added 206.16%	3,328 $107,000
Q1 2019 May 16, 2019	SELL	$22.22 - $32.21 $287,904 - $417,344	-12,957 Reduced 79.56%	3,328 $107,000
Q1 2019 May 15, 2019	BUY	$22.22 - $32.21 $287,904 - $417,344	12,957 Added 389.33%	16,285 $569,000
Q4 2018 Jul 13, 2023	BUY	$20.9 - $32.57 $69,555 - $108,392	3,328 New	3,328 $81,000
Q4 2018 Feb 14, 2019	BUY	$20.9 - $32.57 $54,319 - $84,649	2,599 Added 356.52%	3,328 $82,000
Q3 2018 Jul 13, 2023	BUY	$29.29 - $36.87 $97,477 - $122,703	3,328 New	3,328 $110 Million
Q3 2018 Nov 14, 2018	SELL	$29.29 - $36.87 $76,124 - $95,825	-2,599 Reduced 78.09%	729 $24,000
Q2 2018 Aug 15, 2018	BUY	$28.9 - $37.31 $96,179 - $124,167	3,328 New	3,328 $0

Others Institutions Holding ALBO

# of Institutions

Shares Held

865

Call Options Held

Put Options Held

View Full List

About ALBIREO PHARMA, INC.

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

More about ALBO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account